comparemela.com

Latest Breaking News On - Sydney limb preservation - Page 1 : comparemela.com

Recce Pharmaceuticals Doses Patients in Phase I/II Clinical Trial of RECCE® 327 for Diabetic Foot Infections

Recce Pharmaceuticals Doses Patients in Phase I/II Clinical Trial of RECCE® 327 for Diabetic Foot Infections
tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.

Sydney
New-south-wales
Australia
United-states
Jordyn-temperato
Andrew-geddes
Guillame-van-renterghem
James-graham
Lifesci-communications
Recce-pharmaceuticals-ltd
Recce-pharmaceuticals
Research-unit

Recce Pharmaceuticals has patients dosed in Phase I/II diabetic foot infection clinical trial

Recce Pharmaceuticals Ltd (ASX:RCE, OTC:RECEF) has dosed patients in a Phase I/II diabetic foot infection (DFI) clinical trial, testing the safety and.

Sydney
New-south-wales
Australia
United-states
James-graham
Recce-pharmaceuticals
Recce-pharmaceuticals-ltd
Research-unit
Liverpool-hospital
South-west
Sydney-limb-preservation
Wound-research-unit

vimarsana © 2020. All Rights Reserved.